Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, and will help health professionals navigate a treatment landscape that has ...

Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a diversified, vertically integrated global healthcare ...

Scott, an internationally recognized neurologist and leader in multiple sclerosis (MS) research and clinical care, has been awarded the 2024 MS Research Award by MS Australia.

Cosmos Health (COSM) announced the filing of a patent application for treatment for multiple sclerosis, a disabling autoimmune disorder ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

Susie Wyss used to inject herself daily with a medication for multiple sclerosis ... modifying therapies are now approved to treat MS. The treatments range from oral medications to infusions ...

Follow-up treatments and regular monitoring are essential for ongoing symptom management. Botox is a valuable tool in the management of multiple sclerosis (MS), addressing key symptoms such as ...